Orthometrix Stock Performance
| OMRX Stock | USD 0.0001 0.00 0.000003% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Orthometrix are completely uncorrelated. Orthometrix right now holds a risk of 0.0%. Please check Orthometrix daily balance of power , to decide if Orthometrix will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Orthometrix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Orthometrix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Last Split Factor 3:2 | Last Split Date 1996-06-17 |
1 | Rubrik Stock Jumps On Q3 Earnings Beat Amid Low Expectations - Investors Business Daily | 12/04/2025 |
Orthometrix | Build AI portfolio with Orthometrix Stock |
Orthometrix Relative Risk vs. Return Landscape
If you would invest 0.01 in Orthometrix on September 24, 2025 and sell it today you would earn a total of 0.00 from holding Orthometrix or generate 0.0% return on investment over 90 days. Orthometrix is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Orthometrix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Orthometrix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orthometrix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Orthometrix, and traders can use it to determine the average amount a Orthometrix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| OMRX |
Based on monthly moving average Orthometrix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orthometrix by adding Orthometrix to a well-diversified portfolio.
Orthometrix Fundamentals Growth
Orthometrix Stock prices reflect investors' perceptions of the future prospects and financial health of Orthometrix, and Orthometrix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Orthometrix Stock performance.
| Return On Asset | -0.46 | ||||
| Profit Margin | (0.66) % | ||||
| Operating Margin | (1.85) % | ||||
| Current Valuation | 74.46 K | ||||
| Price To Earning | (0.31) X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 1.07 M | ||||
| Gross Profit | 591.05 K | ||||
| EBITDA | (534.46 K) | ||||
| Net Income | 63.54 K | ||||
| Cash And Equivalents | 2.33 K | ||||
| Total Debt | 630.94 K | ||||
| Current Ratio | 0.13 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | 232.94 K | ||||
| Market Capitalization | 74.46 K | ||||
| Total Asset | 295.86 K | ||||
| Retained Earnings | (47.22 M) | ||||
| Working Capital | 360 K | ||||
| Current Asset | 504 K | ||||
| Current Liabilities | 144 K | ||||
About Orthometrix Performance
Evaluating Orthometrix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Orthometrix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Orthometrix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 69.94 | 123.92 | |
| Return On Tangible Assets | 0.59 | 0.62 | |
| Return On Capital Employed | 0.46 | 0.48 | |
| Return On Assets | 0.59 | 0.62 | |
| Return On Equity | (0.19) | (0.18) |
Things to note about Orthometrix performance evaluation
Checking the ongoing alerts about Orthometrix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Orthometrix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Orthometrix generated a negative expected return over the last 90 days | |
| Orthometrix has some characteristics of a very speculative penny stock | |
| Orthometrix is unlikely to experience financial distress in the next 2 years | |
| Orthometrix currently holds 630.94 K in liabilities. Orthometrix has a current ratio of 0.13, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Orthometrix's use of debt, we should always consider it together with its cash and equity. | |
| Latest headline from news.google.com: Rubrik Stock Jumps On Q3 Earnings Beat Amid Low Expectations - Investors Business Daily |
- Analyzing Orthometrix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Orthometrix's stock is overvalued or undervalued compared to its peers.
- Examining Orthometrix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Orthometrix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Orthometrix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Orthometrix's stock. These opinions can provide insight into Orthometrix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Orthometrix Stock Analysis
When running Orthometrix's price analysis, check to measure Orthometrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthometrix is operating at the current time. Most of Orthometrix's value examination focuses on studying past and present price action to predict the probability of Orthometrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthometrix's price. Additionally, you may evaluate how the addition of Orthometrix to your portfolios can decrease your overall portfolio volatility.